| Issue Date | Title | Author(s) |
| 2012-11-01 | Biofilm dispersal cells of a cystic fibrosis Pseudomonas aeruginosa isolate exhibit variability in functional traits likely to contribute to persistent infection | Woo, JKK; Webb, JS; Kirov, SM; Kjelleberg, S; Rice, SA |
| 2012-09-03 | Cephalosporin-3'-diazeniumdiolates: Targeted NO-donor prodrugs for dispersing bacterial biofilms | Barraud, N; Kardak, BG; Yepuri, NR; Howlin, RP; Webb, JS; Faust, SN; Kjelleberg, S; Rice, SA; Kelso, MJ |
| 2020-06 | Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against Pseudomonas aeruginosa Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model. | Rineh, A; Soren, O; McEwan, T; Ravikumar, V; Poh, WH; Azamifar, F; Naimi-Jamal, MR; Cheung, C-Y; Elliott, AG; Zuegg, J; Blaskovich, MAT; Cooper, MA; Dolange, V; Christodoulides, M; Cook, GM; Rice, SA; Faust, SN; Webb, JS; Kelso, MJ |
| 2012-02-21 | Dynamic modelling of cell death during biofilm development | Fagerlind, MG; Webb, JS; Barraud, N; McDougald, D; Jansson, A; Nilsson, P; Harlén, M; Kjelleberg, S; Rice, SA |
| 2017-09-06 | Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis | Howlin, RP; Cathie, K; Hall-Stoodley, L; Cornelius, V; Duignan, C; Allan, RN; Fernandez, BO; Barraud, N; Bruce, KD; Jefferies, J; Kelso, M; Kjelleberg, S; Rice, SA; Rogers, GB; Pink, S; Smith, C; Sukhtankar, PS; Salib, R; Legg, J; Carroll, M; Daniels, T; Feelisch, M; Stoodley, P; Clarke, SC; Connett, G; Faust, SN; Webb, JS |
| 2009-05-13 | Pseudomonas aeruginosa PAO1 preferentially grows as aggregates in liquid batch cultures and disperses upon starvation | Schleheck, D; Barraud, N; Klebensberger, J; Webb, JS; McDougald, D; Rice, SA; Kjelleberg, S |
